esmo 2018: cohen reflects on practice-changing data in head and neck cancer
Published 5 years ago • 270 plays • Length 11:21Download video MP4
Download video MP3
Similar videos
-
7:42
experts reflect on their highlights from esmo 2018
-
1:46
dr. cohen discusses research questions in head and neck cancer
-
2:07
dr. cohen on challenges with immunotherapy in head and neck cancer
-
1:59
dr. cohen discusses immunotherapy combinations in head and neck cancer
-
1:36
dr. cohen on immunotherapeutic advances in head and neck cancer
-
1:33
dr. cohen on the era before immunotherapy in head and neck cancer
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
-
1:43
dr. cohen on the quality of life in head and neck cancer
-
1:06
dr. cohen discusses the keynote-040 trial in head and neck cancer
-
1:37
dr. cohen on the value of pfs as an endpoint in head and neck cancer
-
1:52
esmo 2022 highlights in head and neck cancer
-
1:59
dr. cohen discusses nk-directed therapy in head and neck cancer
-
1:15
dr. cohen on mtor inhibition in head and neck cancer
-
1:59
dr. cohen discusses promise of immunotherapy in head and neck cancer
-
10:48
esmo 2018: practical implications of new data on non-muscle invasive bladder cancer
-
2:08
dr. cohen discusses entrectinib in head and neck cancer
-
0:55
dr. hong on advances in head and neck cancer
-
2:39
jean bourhis, esmo 2019 - debio 1143 in head and neck cancer
-
1:06
lung cancer highlights from esmo 2022